Alopecia Areata Market Size & Outlook, Scope

reworld90

41
views

Alopecia Areata Market Size & Outlook, Scope

Description

Data Bridge Market Research analyses that the alopecia areata market was valued at USD 2.795 billion in 2021 and is expected to reach USD 4.49 billion by 2029, registering a CAGR of 6.10% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Analysis and Size

Alopecia areata refers to a common autoimmune condition which results in sporadic hair loss. According to the National Institute for Health and Care Excellence (NICE), the prevalence of alopecia in the United Kingdom was projected to be 15 per 10,000 people in 2020. It can affect people of all ages, but it is most prevalent throughout childhood and adolescence. Between the ages of 15 and 29, there was a peak in incidence. 50-60% of males experience their first bald spot before the age of 21.

Market Definition

Alopecia areata (AA) is an autoimmune disease that causes hair to fall out in small patches that are initially unnoticed but eventually become apparent when the hair grows back. When the autoimmune system attaches to the hair follicles, hair loss occurs. Alopecia universalis is a condition that causes total hair loss and prevents hairs from coming back; however, the severity of the condition varies from person to person. Hair loss can affect other parts of the body as well as the face, such as the eyebrows, eyelashes, and beard. When it comes to hair loss, men are more likely than women to have a family history of it.

Report Scope and Market Segmentation

· Segments Covered: Type (Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia, Others), Diagnosis (Trichoscopy, Skin Biopsy, Others), Treatment (Medical Treatments, Natural Treatment, Others), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

· Countries Covered : U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

· Market Players Covered : F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (US)GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), Allergan (Ireland), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Cipla Inc. (US), Abbott (US), AbbVie Inc. (US), Merck KGaA (Germany), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Baxter (US), Hikma Pharmaceuticals PLC (UK), LEO Pharma A/S (Denmark), Bausch Health Companies Inc. (Canada), Perrigo Company plc (Ireland)

Global Alopecia Areata Market Scope

The alopecia areata market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

· Patchy Alopecia Areata

· Alopecia Totalis

· Alopecia Universalis

· Diffuse Alopecia Areata

· Ophiasis Alopecia

· Others

Treatment

· Medical Treatments

· Topical agents

· Steroid injections

· Oral immunosuppressants

· Light therapy

· Others

· Natural Treatment

· Herbal supplements

· Aromatherapy

· Micro needling

· Acupuncture

· Probiotics

· Others

Diagnosis

· Trichoscopy

· Skin Biopsy

· Others

Route of Administration

· Oral

· Topical

· Parenteral

· Others

End-Users

· Hospitals

· Specialty Clinics

· Homecare

· Others

Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· Online Pharmacy

· Others

Alopecia Areata Market Regional Analysis/Insights

The alopecia areata market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the alopecia areata market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the alopecia areata market because of the growing prevalence of autoimmune diseases in this region. Additionally, rising healthcare expenditure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to easily availability of over-the-counter (OTC) drugs and surging hair loss treatment by herbal and synthetic medicines in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.

Major TOC of the Alopecia Areata Market Report

Chapter One:

· MARKET SEGEMENTATION

· EXECUTIVE SUMMARY

· PREMIUM INSIGHTS

· MARKET OVERVIEW

Get TOC of the Report: https://www.databridgemarketresearch.com/reports/global-cardiac-point-of-care-testing-kits-market

Competitive Landscape and Alopecia Areata Market Share Analysis

The Alopecia areata market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to alopecia areata market.

Some of the major players operating in the alopecia areata market are:

· F. Hoffmann-La Roche Ltd. (Switzerland)

· Mylan N.V. (US)

· Teva Pharmaceutical Industries Ltd. (Ireland)

· Sanofi (France)

· Pfizer Inc. (US)

· GlaxoSmithKline plc (UK)

· Novartis AG (Switzerland)

· Bayer AG (Germany)

· Eli Lilly and Company (US)

· Merck & Co., Inc. (US)

· Allergan (Ireland)